title: [Withdrawal of Pneumocystis carinii pneumonia prophylaxis in patients receiving efficacious combined antiretroviral treatment. Study of 85 cases].
abstract: OBJECTIVE
  To analyse the incidence of Pneumocystis carinii pneumonia after the withdrawal of prophylaxis, in patients with AIDS who were receiving HAART (highly active antiretroviral treatment).
  
  
  METHODS
  Prospective opened study of 85 patients with AIDS (CD4 lymphocytes < 200 x 10(6)/l) and whose CD4 counts had increased over 200 x 10(6)/l after HAART, 79 were under primary prophylaxis and six secondary.
  
  
  RESULTS
  Mean CD4 lymphocytes count at the time of withdrawal was 343 x 10(6)/l. Mean time of follow-up after withdrawal was 358 days (range: 93-1,487; median: 302). None of the patients have had Pneumocystis carinii or toxoplasmosis after withdrawal of prophylaxis.
  
  
  CONCLUSIONS
  Pneumocystis carinii prophylaxis in AIDS patients might be safety withdrawn after effective HAART.
authors.affiliation: División de Enfermedades Infecciosas, Fundación Jiménez Díaz, Universidad Autónoma de Madrid.
authors.forename: E
authors.initials: E
authors.lastname: García Vázquez
authors.forename: M
authors.initials: M
authors.lastname: de Górgolas Hernández
authors.forename: R
authors.initials: R
authors.lastname: García Delgado
authors.forename: M L
authors.initials: ML
authors.lastname: Fernández Guerrero
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000163:Acquired Immunodeficiency Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010419:Pentamidine / Q000627:therapeutic use; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control*; D011446:Prospective Studies; D011739:Pyrimethamine / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D000890:Anti-Infective Agents; D000935:Antifungal Agents; D013450:Sulfones; D013411:Sulfadiazine; D010419:Pentamidine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D011739:Pyrimethamine